Scientists identify enzymes implicated in Alzheimer'sBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7218.1151a (Published 30 October 1999) Cite this as: BMJ 1999;319:1151
- Fred Charatan
A team of scientists working at Amgen, a leading biotechnology company at Thousand Oaks, California, has succeeded in identifying two proteases believed to be responsible for the formation of amyloid plaques in the brains of patients with Alzheimer's disease.
Their report is published in the current issue of Science (1999;286:735-41) Amyloid has been clearly implicated in the pathogenesis of Alzheimer' sdisease (BMJ 1998;317:102). The Amgen team found that the deposition …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial